Ironwood Pharmaceuti (IRWD) | |||
---|---|---|---|
11.7 -0.17 (-1.43%) | 08-08 16:00 | ||
Open: | 11.95 | Pre. Close: | 11.87 |
High: | 11.965 | Low: | 11.515 |
Volume: | 2,652,914 | Market Cap: | 1,800M |
Prices Prediction (Update @5:00pm) | ||
---|---|---|
If tomorrow: | Open lower | Open higher |
High: | 11.977 - 12.038 | 12.038 - 12.085 |
Low: | 11.38 - 11.443 | 11.443 - 11.492 |
Close: | 11.599 - 11.706 | 11.706 - 11.788 |
Stock Technical Analysis | |
---|---|
Overall: | ![]() ![]() ![]() |
Target: | Six months: 14.59 One year: 17.04 |
Support: | Support1: 11.43 Support2: 10.78 |
Resistance: | Resistance1: 12.49 Resistance2: 14.59 |
Pivot: | 11.69 ![]() |
Moving Averages: | MA(5): 11.41 ![]() MA(20): 11.72 ![]() MA(100): 11.84 ![]() MA(250): 11.96 ![]() |
MACD: | MACD(12,26): -0.05 ![]() Signal(12,26,9): -0.02 ![]() |
%K %D: | %K(14,3): 52.83 ![]() %D(3): 39.51 ![]() |
RSI: | RSI(14): 50.57 ![]() |
52-Week: | High: 14.27 Low: 10.13 Change(%): -12.5 |
Average Vol(K): | 3-Month: 3932 10-Days: 3221 |
Price, MAs and Bollinger Bands |
---|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IRWD ] has closed below upper band by 49.2%. Bollinger Bands are 51.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue. |
Stock chart |
---|
![]() |
Financial Analysis | |
---|---|
Price to Book Value: | Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
Price to Earnings: | Outperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
Discounted cash flow: | Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
Return on Assets: | Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
Return on Equity: | Neutral |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
Debt to Equity: | Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Stock Basics & Statistics | |
---|---|
Exchange: NASDAQ Global Select | |
Sector: Healthcare | |
Industry: Drug Manufacturers—Specialty & Generic | |
Shares Out. (M) | 153.84 |
Shares Float (M) | 134.43 |
% Held by Insiders | 1.80 |
% Held by Institutions | 111.75 |
Shares Short (K) | 17510 |
Shares Short Prior Month (K) | 14080 |
Stock Financials | |
---|---|
EPS | 3.290 |
Book Value (p.s.) | 3.340 |
Profit Margin | 124.83 |
Operating Margin | 57.91 |
Return on Assets (ttm) | 18.2 |
Return on Equity (ttm) | 167.9 |
Qtrly Rev. Growth | 9.8 |
Gross Profit (p.s.) | 2.232 |
Sales Per Share | 2.746 |
EBITDA (p.s.) | 1.600 |
Qtrly Earnings Growth | -15.10 |
Operating Cash Flow (M) | 252.32 |
Levered Free Cash Flow (M) | 147.22 |
Stock Valuation | |
---|---|
PE Ratio | 3.56 |
PEG Ratio | 0.13 |
Price to Book value | 3.50 |
Price to Sales | 4.26 |
Price to Cash Flow | 7.13 |
Stock Dividends | |
---|---|
Dividend | |
Dividend Yield | |
Dividend Growth |